Glycometabolic reprogramming-mediated XRCC1 lactylation confers therapeutic resistance in high ALDH1A3-expressing glioblastomas
Published: 28 June 2023| Version 1 | DOI: 10.17632/r8hc54x6bf.1
Contributor:
Wei ZhangDescription
This dataset supports the submitted article "Glycometabolic reprogramming-mediated XRCC1 lactylation confers therapeutic resistance in high ALDH1A3-expressing glioblastomas". It includes one text file of mRNA sequencing for glioblastoma stem cells (GSCs), one text file for non-targeted metabolomics analyses in GSCs and two text files to show the immunoprecipitation-mass spectrometry (IP-MS) analysis in GSCs.
Files
Institutions
- Beijing Neurosurgical InstituteBeijing
- Beijing Tiantan HospitalBeijing
- Capital Medical UniversityBeijing
Categories
Glucose Metabolism, Immunoprecipitation, Glioma
Funders
- Ministry of Science and Technology of the People's Republic of ChinaBeijing, ChinaGrant ID: 2019YFE0109400